Micardis hct and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Micardis hct (hydrochlorothiazide; telmisartan), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Drowsiness when taking Micardis hct. It is created by eHealthMe based on reports of 840 people who have side effects when taking Micardis hct from the FDA, and is updated regularly.

What is Micardis hct?

Micardis hct has active ingredients of hydrochlorothiazide; telmisartan. It is often used in high blood pressure. eHealthMe is studying from 1,094 Micardis hct users. Check the latest studies of Micardis hct.

What is Drowsiness?

Drowsiness is found to be associated with 2,866 drugs and 4,796 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Apr, 13, 2026

840 people reported to have side effects when taking Micardis hct.
Among them, 16 people (1.9%) have Drowsiness.

Among these 16 people:

How long have people been on Micardis hct when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Micardis hct? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Drowsiness when taking Micardis hct? *

What are other drugs people take besides Micardis hct? *

What are other side effects people have besides Drowsiness? *

Drug Ineffective: 3 people, 18.75%
Dry Mouth: 3 people, 18.75%
Dizziness: 3 people, 18.75%
Confusional State: 2 people, 12.50%
Insomnia (sleeplessness): 2 people, 12.50%
Migraine (headache): 2 people, 12.50%
Muscle Spasms (muscle contraction): 2 people, 12.50%
Feeling Abnormal: 2 people, 12.50%
Fatigue (feeling of tiredness): 2 people, 12.50%
Heart Rate Increased: 2 people, 12.50%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 18.75%
Migraine (headache): 2 people, 12.50%
Diabetes: 2 people, 12.50%
High Blood Cholesterol: 2 people, 12.50%
Weight Decreased: 1 person, 6.25%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 6.25%
Bipolar Disorder (mood disorder): 1 person, 6.25%
Bladder Disorder: 1 person, 6.25%
Bone Disorder: 1 person, 6.25%
Breast Cancer: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Micardis hct and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micardis hct:

Micardis hct (1,094 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

How severe was Drowsiness and when was it recovered:

Drowsiness in Micardis hct

Expand to all the drugs that have ingredients of hydrochlorothiazide; telmisartan:

Drowsiness and drugs with ingredients of hydrochlorothiazide; telmisartan (21 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micardis hct:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,866 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,796 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; telmisartan (the active ingredients of Micardis hct) and Micardis hct (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.